CASTLE BIOSCIENCES INC (CSTL) — research page
US · us-cm-kg/NASDAQ/CSTL · as of 2026-11-08
Identity and listing
CASTLE BIOSCIENCES INC is listed on NASDAQ under the ticker CSTL, with ISIN US14843C1053 and LEI 2549007M2Q4HLR1XD252. Its security type is Corporate, its segment is not on the record, its sector is 8071 Services-Medical Laboratories, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | CASTLE BIOSCIENCES INC | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | CSTL | source · 2026-11-08 |
| ISIN | US14843C1053 | source · 2026-09-18 |
| LEI | 2549007M2Q4HLR1XD252 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 8071 Services-Medical Laboratories | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 143 filings on 87 filing days in the window 2025-11-08 to 2026-11-08. Of these, 89 are directors' dealings, 42 are regulatory filings, 9 are results and 3 are AGM/EGM filings. The median gap between filing days is 3.0 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date of 2026-11-08. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. The 8071 Services-Medical Laboratories sector median is 79 filings, a median cadence gap of 5.5 days and a median latency of 3 days across 29 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 143 | 3 | 3 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 8071 Services-Medical Laboratories (29 issuers) | 79 | 5.5 | 3 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-05 | results | 10-Q | 10-Q — 10-Q |
| 2026-11-05 | results | 8-K | 8-K — 8-K (items 2.02,7.01,9.01) |
| 2026-11-04 | directors_dealings | 4 | 4 — FORM 4 |
| 2026-11-02 | regulatory_filing | 144 | 144 |
| 2026-10-30 | directors_dealings | 4 | 4 — FORM 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is KPMG LLP, located in Houston, TX. The record holds no auditor changes.
Events and halts
The record holds listing lines dated 2026-08-14 and 2026-08-17. It holds no delisting, name change or domicile change entries, and the domicile change field is not on the record. The segment move field is not on the record. The halt flag shows listed, not halted.
Orderability
The orderability outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's investor-relations page names 10 research houses: Baird, BTIG, Canaccord, Guggenheim, KeyBanc, Mizuho Securities, Roth Capital Partners, Stephens, Lake Street and Leerink Partners.
| research house | analyst | source · read date |
|---|---|---|
| Baird | Robert Bamberger | issuer page · 2026-11-11 |
| BTIG | Mark Massaro | issuer page · 2026-11-11 |
| Canaccord | Kyle Mikson | issuer page · 2026-11-11 |
| Guggenheim | Subbu Nambi | issuer page · 2026-11-11 |
| KeyBanc | Paul Knight | issuer page · 2026-11-11 |
| Mizuho Securities | Bradley Bowers | issuer page · 2026-11-11 |
| Roth Capital Partners | Max Masucci | issuer page · 2026-11-11 |
| Stephens | Mason Carrico | issuer page · 2026-11-11 |
| Lake Street | Thomas Flaten | issuer page · 2026-11-11 |
| Leerink Partners | Puneet Souda | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001447362.json (identity.jurisdiction)
- 10.4
- https://api.gleif.org/api/v1/lei-records/2549007M2Q4HLR1XD252 (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/CSTL (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1447362/000162828026012272/cstl-20251231.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://ir.castlebiosciences.com/stock-data/analyst-coverage (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NASDAQ/CSTL (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US14843C1053"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:8f8c16aff53c0feb.